Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Galera Therapeutics
2 West Liberty Boulevard, Suite 110
Malvern, PA 19355
Phone: 610-725-1500

Galera Therapeutics, Inc. is a clinical-stage biotechnology company, headquartered in Malvern, PA, focused on the development of breakthrough drugs targeting oxygen metabolic pathways. The Company's lead compounds are highly selective small molecule dismutase mimetics that closely mimic the activity of the human superoxide dismutase enzymes. While the biology of the superoxide dismutase family suggests a broad range of potential applications, Galera is initially focusing its development on the prevention of radiation-induced toxicity, including mucositis, and the treatment of cancer.

Key Contact
Name
J. Mel Sorensen
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/11/12 $11,000,000 Series A Correlation Ventures
Novartis Venture Funds
undisclosed
10/14/15 $37,000,000 Series B Correlation Ventures
Galera Angels
Novartis Venture Funds
Novo Ventures
undisclosed
02/03/16 $5,000,000 Series B
11/28/16 $15,000,000 Series B Sofinnova Ventures
undisclosed
09/20/18 $150,000,000 Series C Adage Capital Management
Clarus Ventures
Correlation Ventures
Galera Angels
HBM Healthcare Investments
Nan Fung
New Enterprise Associates
Novartis Venture Funds
Novo Ventures
RA Capital
Rock Springs Capital
Tekla Capital Management
undisclosed